CAV1 and Miyoshi myopathy: Additionally, CAV1 knockdown increased the cell surface death receptor Fas, which was also positively correlated with the PFS of bortezomib‐treated MM patients in Mulligan's cohort (Figure S3G,H, Supporting Information).